Hyperion DeFi, Inc. (HYPD)

Market Cap	55.63M +66.1%
Revenue (ttm)	1.40M +3,052.0%
Net Income	-17.85M
EPS	-1.83
Shares Out	15.54M
PE Ratio	n/a
Forward PE	5.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,462,262
Open	3.320
Previous Close	3.300
Day's Range	3.170 - 3.670
52-Week Range	2.340 - 15.000
Beta	2.53
Analysts	Strong Buy
Price Target	7.20 (+101.12%)
Earnings Date	Aug 12, 2026

About HYPD

Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Jan 25, 2018
• Employees: 9
• Stock Exchange: NASDAQ
• Ticker Symbol: HYPD
• Website: https://hyperiondefi.com

Financial Performance

In 2025, Hyperion DeFi's revenue was $813,455, an increase of 1318.75% compared to the previous year's $57,336. Losses were -$47.00 million, -5.66% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for HYPD stock is "Strong Buy." The 12-month stock price target is $7.2, which is an increase of 101.12% from the latest price.

Price Target

$7.2

(101.12% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 8, 2026

Data Sources Report a data error